Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Fertil Steril. 2010 Jul 15;95(1):281–284. doi: 10.1016/j.fertnstert.2010.06.004

Magnetic Resonance Elastography of Uterine Leiomyomas: A Feasibility Study

Elizabeth A Stewart a, F Andrei Taran a, Jun Chen b, Bobbie S Gostout a, David A Woodrum b, Joel P Felmlee b, Richard L Ehman b
PMCID: PMC3138495  NIHMSID: NIHMS223602  PMID: 20633880

Abstract

Objective

To determine the feasibility of performing in vivo magnetic resonance elastography (MRE) for uterine leiomyoma.

Design

Pilot study

Setting

Academic Medical Center

Patients

Six subjects planning surgical excision of uterine leiomyomas.

Intervention

MRE prior to planned surgery

Main Outcome Measures

Achieving an appropriate phase signal to noise ratio (PSNR) in the leiomyoma to allow assessment of leiomyoma elasticity in kilo pascals (kPa).

Results

MRE was successful in all subjects for uteri ranging from 100 to over 1000 grams. Subjects had body mass indices (BMIs) ranging from 23.0 to 38.0 kg/m2. Appropriate PSNR ranging from 5.45 to 42.28 were achieved for leiomyomas in all subjects. Mean elasticity of uterine leiomyomas ranged from 3.95 to 6.68 kPa.

Conclusion(s)

MRE is a feasible technique for studying the in vivo mechanical properties of uterine leiomyomas and demonstrates significant heterogeneity in elasticity between lesions. Further work is necessary to optimize the technique and understand the clinical utility of this technique for women with uterine leiomyomas.

Keywords: leiomyomas, magnetic resonance, elasticity, uterus, feasibility studies, Elasticity imaging techniques/methods, adult, humans, female

Introduction

Leiomyomas are benign myometrial neoplasms characterized by the presence of excessive extracellular matrix (ECM) that is both structurally and functionally important (1). The ECM in leiomyomas is dynamically regulated throughout the menstrual cycle and serves as a reservoir for growth factors active in leiomyoma biology (24). Additionally, the arrangement of ECM proteins also has been shown to be abnormal in leiomyomas and there is evidence that there is altered mechanical homeostasis in leiomyomas leading to activation of solid-state signaling (5, 6).

Leiomyomas are typically firmer on palpation than the surrounding myometrium and thus they are typically referred to as fibroids. The mechanical property of soft tissues measured by palpation is elasticity, which compares the ratio of a given stress to the resulting strain. Elasticity of soft tissues varies over several orders of magnitude and produces a wider range of values than captured by other types of imaging such as x-ray absorption or magnetic resonance relaxation times (7). In vitro ultrasound strain imaging has demonstrated the elastic variability of uteri containing leiomyomas and endometrial polyps in excised hysterectomy specimens (8)

Magnetic Resonance Elastography (MRE) assesses mechanical properties of in vivo tissues in a three step process: First, an external vibrating mechanical driver coupled to the human body transmits shear waves into the relevant tissue. Secondly; a MRE wave imaging sequence is designed to capture images of the propagating shear waves in the tissue. Finally, an MRE algorithm is used to analyze the resulting wave images and calculate stiffness map of the tissue called an elastogram (9).

In vitro and in vivo data shows that elastic modulus significantly correlates with pathological findings of diseased tissues. Data from breast specimens have consistently shown shear modulus of various types of carcinoma are much higher than the value of normal adipose-glandular tissue (1012). In vivo hepatic elastographic data shows that fibrotic or cirrhotic livers are much firmer than normal ones(1319); while benign liver tumors are significantly softer than malignant ones(20).

Our hypothesis is that leiomyomas differ in elasticity. The primary aim of this pilot study was to investigate the feasibility of MRE for uterine leiomyomas and to obtain data regarding the variability of leiomyoma elasticity in vivo.

Material and Methods

Patient Population and Data Collection

This in vivo MRE study was conducted at the Mayo Clinic, Rochester, MN. MRE has been determined to be a nonsignificant risk procedure by the Mayo Clinic Institutional Review Board, which approved this study. Written consent was obtained from all participants prior to the study. Study procedures were in accordance with ethical standards set forth in the revised Declaration of Helsinki. Women with planned excisional surgery for uterine leiomyomas between April 2008 and March, 2009 were eligible for inclusion.

Magnetic Resonance Elastography

Magnetic Resonance Elastography (MRE) scans were performed on a 1.5 T whole-body imager (Signa, GE Healthcare, Milwaukee, WI, USA). Participants were imaged in the supine position with a 19 cm diameter passive driver placed on their abdomen above the uterus together with a custom-built four element phased array MRI imaging coil. Continuous acoustic vibrations at 60 Hz were transmitted from an active driver in the equipment room to the passive driver through a flexible vinyl tube, which is transmitting shear waves into the uterus. A modified 2-D gradient recalled echo (GRE) based elastography pulse sequence was used to collect wave images with the following parameters: imaging plane=axial or sagittal; FOV=24–42cm; matrix =256×64; fractional phase FOV=0.75–1; flip angle= 30°; NEX=1; Bandwidth =15.63–31.25 kHz; TR=50 msec; TE=24.9–28.5 msec; slice thickness =4–5 mm; slice position = through the uterine fibroid; phase offsets = 4 or 8; MENC = 30.7–31.7 μm/π-radian; motion-sensitizing-gradient (MSG) frequency=60Hz; MSG direction= RL (right-Left), AP (anterior-posterior) and SI (superior-inferior); MRE wave images were collected on the respective 3 motion-sensitizing-gradient directions.

Those 3 motion-sensitizing-gradient directional wave images were processed into a quantitative elastogram with units of kilopascal (kPa) using a previously described 2-D local frequency estimation (LFE) MRE inversion algorithm (21, 22). Before applying the 2-D LFE algorithm the low spatial frequency background bulk motion and the high spatial frequency noise were removed from the wave data with a broadband Gaussian bandpass filter (16.67–111.11 waves/meter). Two dimensional directional filtering with 8 evenly spaced angles and a 2-D Butterworth bandpass filter with the same bandwidth were also applied to the wave data to improve accuracy of the 2-D LFE algorithm which is limited by the low phase signal-to-noise ratio (PSNR) caused by complex wave interferences. The directional filter separates the complex wave fields into components propagating in different directions and analyzes each of them separately (23). All of the patient data were processed consistently with the same parameters. Regions of interest (ROI) were drawn manually on the elastograms to correspond to the leiomyomas and mean, standard deviation and histograms of the tissue stiffness in the ROI were reported. An appropriate PSNR was used to aid in drawing the ROI and confirms the integrity of the signal. Interpretation of MRE was performed in a blinded fashion without knowledge of clinical information for the participants.

Results

Clinical characteristics of study participants are presented in Table 1. Six women participated in the study with a mean age of 42 ± 10 years (range 34–60). Average time interval from MR Elastography study to surgical intervention was 8 days (range 1–20 days) and the mean BMI of all patients: was 28.9 ± 6.2 kg/m2 (range 23.0 – 38.0 kg/m2)

Table 1.

Characteristics of the Study Participants (N=6)

Subject Age Gravidity/Parity BMI Hormonal Status Race Indication for Surgery Surgery
1 34 1/1 24.2 Premenopausal / Secretory Phase Caucasian Enlarging Uterus, Menorrhagia Hysterectomy
2 37 2/0 33.7 Premenopausal African-American Enlarging fibroids Myomectomy
3 40 2/1 23.1 Premenopausal / Proliferative Phase Asian Degenerating fibroid and preterm labor Myomectomy
4 44 0/0 30.7 Premenopausal / Proliferative Phase Caucasian Increasing heavy menses and bulk symptoms Hysterectomy
5 60 3/3 38 Postmenopausal Caucasian Enlarging myoma in menopause Hysterectomy
6 36 1/1 23.7 Premenopausal / Noncycling on OCPs Asian Probable recurrent adenomyosis Diagnostic Hysteroscopy

The first five subjects had clinical MRI studies with gadolinium prior to enrollment in the study allowing assessment of image characteristics. Subject six had a presumed recurrent adenomyoma based on an abnormal ultrasound and her history of resection of a large adenomyoma 8 months prior to the MRE study. However, subsequent hysteroscopic surgery showed only an enlarged uterus and she conceived two months following the MRE and is currently in the third trimester of gestation. Thus, neither pretreatment MR imaging nor uterine histology is available for this subject.

Studied leiomyomas ranged in size from. 4.5 to 22.5 cm in mean diameter and most had MR imaging characteristics of typical leiomyomas (Table 2). MRE was successfully performed in all subjects and uterine leiomyomas were confirmed in all subjects undergoing either myomectomy or hysterectomy (Figure 1). All subjects had appropriate PSNR to allow valid measurements of leiomyomas stiffness (Table 2). Mean elasticity for the studied fibroids ranged from 3.95 to 6.68 kPa and histograms were generated for each subject (Figure 2).

Table 2.

MRI characteristics, pathology findings and MRE data

MRI Characteristics Pathology Findings MRE Data

Subject number T1 images T2 images Gadolinium enhancement Histologic Diagnosis Diameter of largest myoma (cm) Weight of excised tissue (g) PSNR MRE (kPa)
1 Iso Dark Heterogeneous Leiomyoma 22 1640 42.28±15.54 5.18 ± 1.1
2 Iso Dark Homogeneous Leiomyoma 11.8 525 22.63±8.00 5.52 ± 1.07
3 Iso Heterogeneous No enhancement Leiomyoma 22.5 930 7.09±1.24 3.95 ± 0.92
4 Iso Dark Homogeneous Adenomyosis and Leiomyoma 8.5 175 5.45±1.67 6.68 ± 1.04
5 Iso Dark Homogeneous Leiomyoma 4.5 99.6 6.86±0.83 5.19 ± 0.26
6 NA NA NA NA 30.7±11.2 4.04 ± 0.73

Figure 1.

Figure 1

shows the MRE study for subject 4. In the top row are coronal, sagittal and axial T2W images from the pretreatment MRI. At the far right the region of interest (ROI) is outlined on the axial image. In the bottom row are MR elastographic wave images with shear waves propagating through the tissue in the X, Y and Z axes and at the far right a composite elastogram with the scale where color represents a change in shear stiffness in kPa.

Figure 2.

Figure 2

Plot of mean leiomyoma stiffness for each subject. The histograms representing the distribution of shear stiffness are shown on the top of plot for each subject.

Discussion

Magnetic resonance elastography (MRE) for uterine leiomyomas appears feasible for studying leiomyomas in uteri ranging from 100 to over 1000 grams and leiomyomas ranging from 4.5 to 22.5 cm in mean diameter. Women with variable body habitus were able to be studied and a significant difference in elasticity was demonstrated among leiomyomas. To place these elasticity values in context, the range of elasticities of these myomas exceeds those reported for benign liver tumors (mean 2.7 kPa, range 1.6–3.2) and produced values similar to those seen for fibrotic liver disease (mean 5.9 kPa, range 3.1–12.2) (20).

This is the first report of in vivo examination of leiomyoma elasticity. Previous in vitro work has utilized ultrasound strain imaging to assess elasticity of extirpated uteri or direct assessment of Young's modulus in small pieces of myometrium and leiomyoma (6, 8, 24, 25). Typically, there are significant differences in elasticity when the same tissues are studied in vivo and then in vitro (7). However, the increased stiffness of leiomyomas relative to myometrium shown in this study does parallel that seen in studies of surgically excised tissue (6).

The variability of elasticity for uterine lesions may be important in preoperatively differentiating rarer uterine masses from the common leiomyoma. While uterine sarcomas are very rare, they are difficult to differentiate from leiomyomas with conventional imaging modalities (26, 27). However uterine sarcomas do tend to be more cellular than leiomyomas and may be able to be distinguished from leiomyomas just as malignant lesions of the liver and breast appear to have different mechanical properties than their benign counterpoints (10, 12, 20). Similarly, there is increasing evidence that cellular leiomyomas may have premalignant potential and thus early identification of these lesions may be beneficial (2830).

The relative concentration of cellular and extracellular components in leiomyomas also may contribute to their response to non-excisional therapies such as uterine artery embolization (UAE) and magnetic resonance guided focused ultrasound surgery (MRgFUS). Since leiomyomas are not removed in these therapies, their relative cellularity may be influencing their response to treatment and thus having a way to assess this variable may prove useful in predicting response to minimally invasive myoma therapies.

A clear limitation to the current pilot study is the small number of subjects studied to date. Additional studies with a larger sample size and other uterine pathology will clearly be needed to gain statistical power to understand if MRE has clinical utility for imaging uterine disease. Additionally, the current two dimensional MRE process used in this group of patients has the limitation of estimating true mechanical stiffness values especially in small lesions. In the next stage, three dimensional MRE should be employed to overcome this limitation. Finally, new MRE mechanical drivers are in development which can be used to improve the mechanical coupling between the driver and the lower abdomen and to increase the wave penetration to deep leiomyomas regions.

Capsule.

In vivo Magnetic Resonance Elastography (MRE) is feasible to perform over a large range of leiomyoma sizes and quantitates variability in the elasticity of uterine leiomyomas.

Acknowledgments

The authors acknowledge the expert assistance of Jennifer L. Kugel who performed the original MRE studies and Tracy L. Brewer for assistance with manuscript preparation.

The project described was supported in part by Grant Number 1 UL1 RR024150 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and the NIH Roadmap for Medical Research.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Where the work was done: Mayo Clinic, Rochester, MN

Presented in part at the 14th World Congress of Gynecologic Endocrinology, Florence, Italy: March 4–7, 2010

References

  • 1.Walker CL, Stewart EA. Uterine Fibroids: The Elephant in the Room. Science. 2005;308:1589–92. doi: 10.1126/science.1112063. [DOI] [PubMed] [Google Scholar]
  • 2.Stewart EA, Friedman AJ, Peck K, Nowak RA. Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle. J Clin Endocrinol Metab. 1994;79:900–6. doi: 10.1210/jcem.79.3.8077380. [DOI] [PubMed] [Google Scholar]
  • 3.Stewart EA, Rhoades AR, Nowak RA. Leuprolide acetate-treated leiomyomas retain their relative overexpression of collagen type I and collagen type III messenger ribonucleic acid. J Soc Gynecol Investig. 1998;5:44–7. doi: 10.1016/s1071-5576(97)00097-x. [DOI] [PubMed] [Google Scholar]
  • 4.Catherino WH, Leppert PC, Stenmark MH, Payson M, Potlog-Nahari C, Nieman LK, et al. Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids. Genes Chromosomes Cancer. 2004;40:204–17. doi: 10.1002/gcc.20035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Leppert PC, Baginski T, Prupas C, Catherino WH, Pletcher S, Segars JH. Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometrium. Fertil Steril. 2004;82(Suppl 3):1182–7. doi: 10.1016/j.fertnstert.2004.04.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Rogers R, Norian J, Malik M, Christman G, Abu-Asab M, Chen F, et al. Mechanical homeostasis is altered in uterine leiomyoma. Am J Obstet Gynecol. 2008;198:474, e1–11. doi: 10.1016/j.ajog.2007.11.057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Duck F. Physical properties of tissue: a comprehensive reference book. Academic Press; San Diego: 1990. [Google Scholar]
  • 8.Hobson MA, Kiss MZ, Varghese T, Sommer AM, Kliewer MA, Zagzebski JA, et al. In vitro uterine strain imaging: preliminary results. J Ultrasound Med. 2007;26:899–908. doi: 10.7863/jum.2007.26.7.899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Muthupillai R, Lomas DJ, Rossman PJ, Greenleaf JF, Manduca A, Ehman RL. Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. Science. 1995;269:1854–7. doi: 10.1126/science.7569924. [DOI] [PubMed] [Google Scholar]
  • 10.Sarvazyan A, Goukassian D, Maevsky E, Oranskaja G, Skovoroda A, Emelianov S, et al. Elasticity imaging as a new modality of medical imaging for cancer detection. International Workshop on Interaction of Ultrasound with Biological Media; Valenciennes, France. 1994. pp. 69–81. [Google Scholar]
  • 11.Burke TM, Blankenberg TA, Sui AKQ, Blankenberg FG, Jensen HM. Preliminary results for shear wave speed of sound and attenuation coefficients from excised specimens of human breast tissue. Ultrasonic Imaging. 1990;12:99–118. doi: 10.1177/016173469001200203. [DOI] [PubMed] [Google Scholar]
  • 12.Krouskop TA, Wheeler TM, Kallel F, Garra BS, Hall T. Elastic moduli of breast and prostate tissues under compression. Ultrasonic Imaging. 1998;20:260–74. doi: 10.1177/016173469802000403. [DOI] [PubMed] [Google Scholar]
  • 13.Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005;41:48–54. doi: 10.1002/hep.20506. [DOI] [PubMed] [Google Scholar]
  • 14.Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound in medicine & biology. 2003;29:1705–13. doi: 10.1016/j.ultrasmedbio.2003.07.001. [DOI] [PubMed] [Google Scholar]
  • 15.Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol. 2008;48:835–47. doi: 10.1016/j.jhep.2008.02.008. [DOI] [PubMed] [Google Scholar]
  • 16.Talwalkar JA. Elastography for detecting hepatic fibrosis: options and considerations. Gastroenterology. 2008;135:299–302. doi: 10.1053/j.gastro.2008.05.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Huwart L, Sempoux C, Vicaut E, Salameh N, Annet L, Danse E, et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology. 2008;135:32–40. doi: 10.1053/j.gastro.2008.03.076. [DOI] [PubMed] [Google Scholar]
  • 18.Ehman RL. Science to practice: can MR elastography be used to detect early steatohepatitis in fatty liver disease? Radiology. 2009;253:1–3. doi: 10.1148/radiol.2531091040. [DOI] [PubMed] [Google Scholar]
  • 19.Asbach P, Klatt D, Hamhaber U, Braun J, Somasundaram R, Hamm B, et al. Assessment of liver viscoelasticity using multifrequency MR elastography. Magn Reson Med. 2008;60:373–9. doi: 10.1002/mrm.21636. [DOI] [PubMed] [Google Scholar]
  • 20.Venkatesh SK, Yin M, Glockner JF, Takahashi N, Araoz PA, Talwalkar JA, et al. MR elastography of liver tumors: preliminary results. AJR Am J Roentgenol. 2008;190:1534–40. doi: 10.2214/AJR.07.3123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Westin CF, Wigstrom L, Loock T, Sjoqvist L, Kikinis R, Knutsson H. Three-dimensional adaptive filtering in magnetic resonance angiography. J Magn Reson Imaging. 2001;14:63–71. doi: 10.1002/jmri.1152. [DOI] [PubMed] [Google Scholar]
  • 22.Dresner MA, Rose GH, Rossman PJ, Muthupillai R, Manduca A, Ehman RL. Magnetic resonance elastography of skeletal muscle. J Magn Reson Imaging. 2001;13:269–76. doi: 10.1002/1522-2586(200102)13:2<269::aid-jmri1039>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  • 23.Manduca A, Lake DS, Kruse SA, Ehman RL. Spatio-temporal directional filtering for improved inversion of MR elastography images. Med Image Anal. 2003;7:465–73. doi: 10.1016/s1361-8415(03)00038-0. [DOI] [PubMed] [Google Scholar]
  • 24.Kiss MZ, Hobson MA, Varghese T, Harter J, Kliewer MA, Hartenbach EM, et al. Frequency-dependent complex modulus of the uterus: preliminary results. Physics in medicine and biology. 2006;51:3683–95. doi: 10.1088/0031-9155/51/15/006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Hobson MA, Madsen EL, Frank GR, Jiang J, Shi H, Hall TJ, et al. Anthropomorphic phantoms for assessment of strain imaging methods involving saline-infused sonohysterography. Ultrasound in medicine & biology. 2008;34:1622–37. doi: 10.1016/j.ultrasmedbio.2008.02.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Goto A, Takeuchi S, Sugimura K, Maruo T. Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus. Int J Gynecol Cancer. 2002;12:354–61. doi: 10.1046/j.1525-1438.2002.01086.x. [DOI] [PubMed] [Google Scholar]
  • 27.Tanaka YO, Nishida M, Tsunoda H, Okamoto Y, Yoshikawa H. Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings. J Magn Reson Imaging. 2004;20:998–1007. doi: 10.1002/jmri.20207. [DOI] [PubMed] [Google Scholar]
  • 28.Christacos NC, Quade BJ, Dal Cin P, Morton CC. Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features. Genes Chromosomes Cancer. 2006;45:304–12. doi: 10.1002/gcc.20291. [DOI] [PubMed] [Google Scholar]
  • 29.Giuntoli RL, 2nd, Gostout BS, DiMarco CS, Metzinger DS, Keeney GL. Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior. J Reprod Med. 2007;52:1001–10. [PubMed] [Google Scholar]
  • 30.Taran FA, Weaver AL, Gostout BS, Stewart EA. Understanding cellular leiomyomas: a case control study. Am J Obstet Gynecol. 2010 doi: 10.1016/j.ajog.2010.03.018. In Press. [DOI] [PubMed] [Google Scholar]

RESOURCES